ClinicalTrials.govpublic full text
IV Busulfan Plus Bortezomib Conditioning Regimen for Second Autologous Stem Cell Transplant in Multiple Myeloma Patients
multiple myeloma, bone marrow transplant, stem cell transplant, busulfan, bortezomib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 897261
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.